Energy metabolism and substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin

被引:6
作者
Avignon, A [1 ]
Lapinski, H [1 ]
Rabasa-Lhoret, R [1 ]
Caubel, C [1 ]
Boniface, H [1 ]
Monnier, L [1 ]
机构
[1] Hop Lapeyronie, Serv Malad Metab, Dept Metab Dis, F-34295 Montpellier 5, France
关键词
type; 2; diabetes; glucose oxidation; sulphonylurea; metformin;
D O I
10.1046/j.1463-1326.2000.00082.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare substrates oxidative patterns in type 2 diabetic patients treated with sulphonylurea alone or in combination with metformin. Methods: Plasma glucose (PG), plasma insulin (PI) and substrates oxidation rates measured by indirect calorimetry were compared during a test day at 8.00 a.m. (before breakfast), 11.00 a.m. (before the lunch), 2.00 p.m. (2 h after the lunch) and at 5.00 p.m. in 56 diabetic patients treated with diet (group C, n = 14), sulphonylurea (group S, n = 14) or with a sulphonylurea-metformin combination (group SM, n = 28). Results: The three groups were comparable for age, body mass index (b.m.i.), body composition and PG levels. Mean glucose oxidation (Gox) was increased since mean lipid oxidation (Lox) was decreased in group S in comparison both with group C (3.02 +/- 0.08 vs. 2.62 +/- 0.08 g/min/kg/10(3), p < 0.05; 0.53 +/- 0.04 vs. 0.88 +/- 0.09 g/min/kg/10(3), p < 0.01). Mean Lox was also decreased in group S in comparison with group SM (0.88 +/- 0.06 vs. 0.53 +/- 0.04 g/min(1)/kg(1)/10(3), p < 0.0001) whereas the difference in Gox between these latter two groups was only significant in the basal state (1.94 +/- 0.17 vs. 2.47 +/- 0.17 g/min(1)/kg(1)/10(3), p < 0.05). Mean respiratory quotient (RQ) was increased in group S (0.90 +/- 0.01) in comparison both with group C (0.86 +/- 0.01, p < 0.001) and with group SM (0.86 +/- 0.01, p < 0.001). Mean energy expenditure was lower in group S than in group SM (21.4 +/- 0.6 vs. 23.6 +/- 0.6 kcal/min/kg/10(3), p < 0.05). Substrates oxidative patterns, RQ values and energy expenditure were similar in group C and in group SM. Conclusions: When compared to patients treated with a sulphonylurea-metformin bitherapy, patients treated with a sulphonylurea monotherapy have a shift in their ratio of fat to carbohydrate oxidation that could make body weight loss more difficult in this latter group.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 29 条
[21]   ACUTE ANTIHYPERGLYCEMIC MECHANISMS OF METFORMIN IN NIDDM - EVIDENCE FOR SUPPRESSION OF LIPID OXIDATION AND HEPATIC GLUCOSE-PRODUCTION [J].
PERRIELLO, G ;
MISERICORDIA, P ;
VOLPI, E ;
SANTUCCI, A ;
SANTUCCI, C ;
FERRANNINI, E ;
VENTURA, MM ;
SANTEUSANIO, F ;
BRUNETTI, P ;
BOLLI, GB .
DIABETES, 1994, 43 (07) :920-928
[22]  
RICCIO A, 1991, DIABETES METAB, V17, P180
[23]  
SHEPHERD M, 1994, DIABETES, V43, pA76
[24]   METABOLIC EFFECTS OF METFORMIN IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
STUMVOLL, M ;
NURJHAN, N ;
PERRIELLO, G ;
DAILEY, G ;
GERICH, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (09) :550-554
[25]  
TURNER RC, 1983, DIABETOLOGIA, V24, P404
[26]  
World Health Organization. Diabetes mellitus: Report of a WHO study group, 1985, WHO TECHN REP SER, V727
[27]   United kingdom prospective diabetes study 24: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy [J].
Wright, A ;
Cull, C ;
Holman, R ;
Turner, R ;
Murchison, L ;
Wright, AD ;
Oakley, N ;
Kohner, E ;
Hayes, R ;
Scarpello, J ;
Hadden, D ;
Spathis, AG ;
Yudkin, J ;
Greenwood, R ;
Borthwick, L ;
Day, J ;
Newton, R ;
Fox, C ;
Paisey, R ;
Roland, J ;
Humphriss, D ;
Peacock, I ;
Boulton, A ;
Dornan, T ;
Burden, F ;
Tooke, J .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :165-175
[28]  
Wright AD, 1998, DIABETES CARE, V21, P87
[29]  
ZURLO F, 1990, AM J PHYSIOL, V259, P650